ArticleAmerican journal of cancer research2021

A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.

Masanori Oshi et al.PubMed ↗Full text ↗

No numbers read from the abstract.